Abstract
Objective To review our initial experience in selecting patients to undergo robotic pancreatic surgery. Methods This is a retrospective study on 100 patients who underwent robotic pancreatic operations at the Chinese PLA General Hospital from September 2009 to March 2015. Results 89 patients underwent robotic pancreatic body and tail resection, 5 patients superficial enucleation of pancreatic lesions, 3 patients middle pancreatic resection, 1 patient pancreaticoduodenectomy, 1 patient pancreatico-gastric ana-stomosis, and 1 patient pancreatico-jejunal anastomosis. Conclusions Robotic pancreatic surgery was safe and feasible. Lesions located in pancreatic body and tail could be treated with resection of pancreatic body and tail, and this appeared to be the best indication for robotic pancreatic surgery. Focal lesions on the surface of pancreas could be enucleated using the Da Vinci robotic surgical system. Extreme care should be exercised in selecting patients for robotic pancreaticoduodenectomy, because the surgical risk is high. Key words: Da Vinci robotic surgical system; Pancreatic operation; Indication
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
